Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Its purpose was to determine whether the drug, which belongs to a class called GLP-1 receptor agonists, could reduce the symptoms of PAD in people with mild to moderate symptoms early in the course of their disease
Selected Sources US Food and Drug Administration
Iowa, Nebraska, & Missouri residents available via telehealth 300 West Welsh Street, Williamsburg, Iowa 52361, United States 319-660-0005 Telehealth available for flexible scheduling
B.AanerudJ.BraendgaardH.GjeddeA
US$ 24.16
US$ 22.76
US$ 25.86
